Resource Summary

Clinical Question:
Do neuramidase inhibitors (NIs) oseltamivir (Tamiflu®) and/or zanamivir (Relenza®) improve clinical outcomes in healthy patients with influenza or influenza-like illness?

Bottom-Line:
Biased^ poor quality^ mostly unpublished evidence demonstrates that oseltamivir and zanamivir shorten the duration of influenza symptoms by -1/2 a day. Objectively defined pneumonia or hospitalizations are not decreased.


*** Original Documents can be found and downloaded using the link provided below ***

https://www.acfp.ca/tools-for-practice/

Publication Date: 2015-2-3
Last Updated on PCR: 2017-03-31 14:29:59